Predict your next investment

Catalio Capital Management company logo
Venture Capital
FINANCIAL | Investment Firms & Funds

See what CB Insights has to offer

Founded Year



Spinoff / Spinout | Alive

About Catalio Capital Management

Catalio Capital Management is focused on investing in a diversified portfolio of biomedical technology companies.

Catalio Capital Management Headquarter Location

New York, New York,

United States

(410) 989-6168

Latest Catalio Capital Management News

StartUPDATES: New developments from healthcare startups

Jul 16, 2021

MedCity News Read about new developments from HealthMine, TailorMed, Heru and Entos. Shares0 HealthMine EVP of Growth Kent Holdcroft recently presented at a Strategic Solutions Network event for Medicare Stars, HEDIS, Quality & Risk. Kent’s presentation addresses how Medicare Advantage plans can use technology to create a personalized digital engagement solution that empowers members to complete important health actions – leading to better consumer experience, higher CAHPS/HOS scores, and improved Star Ratings. To access the full recording, click here . TailorMed is a fintech meets health tech company that helps healthcare organizations remove financial barriers to care. It does so by providing insurance optimization for patients and offers a range of services such as tracking, matching, and enrolling patients in financial assistance programs, government plans, drug co-pay, free drug programs, and non-medical assistance programs based on their insurance, clinical and demographic data. TailorMed is collaborating with AllianceRx Walgreens to make specialty medications affordable across their 330 locations. The deal comes on the heels of a $20 million funding round led by Providence Ventures with participation from new investors UnityPoint Health Ventures, Almeda Ventures, Bridges Israel and Discount Capital and existing investors Accelmed, Sanara Ventures and Triventures. “We are excited to leverage TailorMed’s technology to help lower specialty prescription costs for our patients,” said Lisa Mymo, vice president, Pharma and Financial Services at AllianceRx Walgreens Prime. “By improving access to these vital, yet expensive therapies, our patients are more likely to adhere to treatment and better manage their rare disease or chronic conditions.” Heru , a developer of wearable AI-powered vision diagnostics and augmentation software, has made several leadership team hires: Mary Durbin as Chief Scientific Officer; previously with Carl Zeiss Meditec, which manufactures tools for eye examinations and other areas of medicine, and Philips Healthcare Bob George as Chief Technology Officer; previously with Amazon Studios Corey Nielson as Chief Customer Officer; previously with Topcon Healthcare, an ophthalmic device manufacturer John Trefethen as Chief Marketing Officer; previously with Topcon Healthcare The new hires follow a $30 million Series A fundraise in May. The funding will be used for  The funding will be used to support the company’s FDA approved Heru RE: eye diagnostic and vision correction and augmentation technology platform. To read more, click here . Entos , which has a biotech platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, closed a $53 million Series A financing round led by Coatue, a technology investment firm, and Catalio Capital Management, a biomedical technology investment firm. The funding round also had participation from OrbiMed, Sequoia Capital and existing investors Nexus Ventures and Freeflow. As part of the fundraise, Aaron Weiner, Managing Director and Head of Healthcare at Coatue, and R. Jacob Vogelstein, Co-Founder and Managing Partner of Catalio, have joined Entos’ Board of Directors. Picture: akindo, Getty Images

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Catalio Capital Management Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Catalio Capital Management Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.